Tag: regulatory approvals
AstraZeneca posts strong Q1 2024 results with significant revenue and EPS growth
AstraZeneca PLC has reported a notable performance in the first quarter of 2024, with total revenue reaching $12,679 million, marking a 19% increase at constant ... Read More
EQT Private Equity to acquire Avetta to bolster global supply chain resilience
EQT Private Equity, under its EQT X fund, announced today a significant strategic acquisition, taking over Avetta from Welsh, Carson, Anderson & Stowe (WCAS). This ... Read More